Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001214659-24-002308
Filing Date
2024-02-12
Accepted
2024-02-12 17:02:07
Documents
4
Effectiveness Date
2024-02-12

Document Format Files

Seq Description Document Type Size
1 j212240s8.htm S-8 37866
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 7439
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 1994
4 EXHIBIT 107 ex107.htm EX-FILING FEES 14619
  Complete submission text file 0001214659-24-002308.txt   63025
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277015 | Film No.: 24621043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)